Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Vale SA — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B), while Vale SA trades at $13.62 (market cap $57.32B). The key difference: Vale SA is far larger — about 2.3× Royalty Pharma plc Class A Ordinary Shares's market cap, and Vale SA pays the higher dividend (8.87%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Vale SA for 109 Days on average.
| RPRX | VALE | |
|---|---|---|
Market Cap | $25.27B | $57.32B |
Volume | 3,671,183 | 27,996,846 |
Sector | Health | Basic Materials |
52-Week High | $63.96 | $17.82 |
52-Week Low | $35.44 | $10.75 |
Typical Hold Time | 1 Days | 109 Days |
Enterprise Value | $32.50B | $73.56B |
Dividend Yield | 1.66% | 8.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VALE stock trades at $13.42, down 1.4% on the day, reflecting recent pressure from earnings misses and sector-wide declines in steel producers. The technical outlook is bearish, with price near key support at $13, while fundamentals show declining net income margins and profit compression amid rising costs. Recent news highlights concerns over iron ore pricing and U.S. steel expansion plans impacting sentiment.
The investment case is mixed: analyst consensus leans Hold with a $16.21 price target, suggesting modest upside, but risks include cyclical commodity exposure, Brazilian regulatory issues, and margin pressure. Base metals growth offers a partial offset, but earnings consistency remains a challenge for near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
